[Therapeutic use of beta-blockers in general pathology (rheumatology, neurology and ophthalmology) (author's transl)].
D007516:Adenoma, Islet Cell / Q000188:drug therapy; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D003920:Diabetes Mellitus / Q000188:drug therapy; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007003:Hypoglycemia / Q000209:etiology; D008881:Migraine Disorders / Q000188:drug therapy; D009069:Movement Disorders / Q000188:drug therapy; D009422:Nervous System Diseases / Q000188:drug therapy*; D010190:Pancreatic Neoplasms / Q000150:complications / Q000188:drug therapy; D012216:Rheumatic Diseases / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists
A propos des nouvelles indications des bêta-bloquants en pathologie générale.